Status:
TERMINATED
A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition
Lead Sponsor:
Pfizer
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-50 years
Phase:
PHASE3
Brief Summary
To assess the impact of inhalation of insulin on glucose disposition in patients with type 1 diabetes
Detailed Description
The study was terminated on Oct. 28, 2007. The protocol was undergoing implementation and methodological issues with major revisions that qualified this trial as a new trial. Pfizer decided to cancel ...
Eligibility Criteria
Inclusion
- Diabetes mellitus Type 1
Exclusion
- Asthma, COPD
- Smoking
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00287066
Start Date
February 1 2006
End Date
March 1 2007
Last Update
February 21 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Pittsburgh, Pennsylvania, United States